ELII: rVSV Vectored Tri-valent Filovirus Vaccine to Protect Against Aerosol Exposure

Project: Research project

Project Details

StatusFinished
Effective start/end date6/30/1411/30/17

Funding

  • Profectus BioSciences Incorporated: $1,831,836.00